Fundz

Sonnet Biotherapeutics, Inc. reported raising $750,000 in an initial SEC Form D filing, from an offering of $750,000

PRIVATEMay 14, 2019

Amount Raised

$750,000

$750,000 sold, per SEC Form D (first sale May 14, 2019)

Round Type

Seed

PrincetonBiotechnologyHealthcare

Who to call at Sonnet BioTherapeutics Holdings, and when

A new round usually means Sonnet BioTherapeutics Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sonnet BioTherapeutics Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sonnet BioTherapeutics Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sonnet BioTherapeutics Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sonnet BioTherapeutics Holdings

Location

100 OVERLOOK CENTER

Princeton, West Virginia, United States

About

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage company developing targeted immunotherapeutic drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sonnet BioTherapeutics Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Sonnet BioTherapeutics Ho…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sonnet BioTherapeutics Holdings's next move

See what Strategic adds

Sonnet BioTherapeutics Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.